Headlands Technologies LLC Biomarin Pharmaceutical Inc Transaction History
Headlands Technologies LLC
- $401 Million
- Q1 2024
A detailed history of Headlands Technologies LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Headlands Technologies LLC holds 5,692 shares of BMRN stock, worth $468,394. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,692
Previous 1,281
344.34%
Holding current value
$468,394
Previous $123,000
304.07%
% of portfolio
0.12%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
621Shares Held
181MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.54 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.49 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.19 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.15 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$567 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...